What's Happening?
EssilorLuxottica, a leading global optics company, has reported its best quarterly revenue since its formation, with sales reaching 6.87 billion euros in the third quarter of 2025. This marks a 6.7% increase
at current exchange rates, surpassing expectations from analysts. The growth was largely driven by the success of smart glasses, particularly in North America and Europe, where sales increased by 11.7% at constant exchange rates. The company has seen exponential growth in its Ray-Ban Meta and Oakley Meta smart glasses, which contributed significantly to the revenue increase. EssilorLuxottica plans to expand production capacity for these glasses and introduce new innovations in the product line.
Why It's Important?
EssilorLuxottica's record revenue growth highlights the increasing consumer demand for smart glasses equipped with artificial intelligence features. This trend reflects a broader shift towards wearable technology and its integration into everyday life. The company's success in this area positions it as a leader in the optics industry, with potential implications for competitors and market dynamics. The expansion of smart glasses production and the introduction of new products could further strengthen EssilorLuxottica's market position and drive innovation in the sector. Additionally, the company's focus on myopia management solutions, such as Stellest lenses, underscores its commitment to addressing global health challenges.
What's Next?
EssilorLuxottica plans to increase its production capacity for smart glasses to 10 million units annually by 2026, with expectations to achieve this sooner. The company is also expanding its Nuance Audio glasses to additional countries, aiming to enhance its product offerings. As EssilorLuxottica continues to innovate, stakeholders will be monitoring its ability to maintain growth momentum and capitalize on emerging trends in wearable technology. The upcoming launch of Stellest lenses in the U.S. represents a strategic move to expand its presence in the myopia management market, potentially influencing public health policies and consumer behavior.
